HealthVC
Subscribe
Sign in
Home
Podcast
Archive
Leaderboard
About
Latest
Top
Discussions
Pricing Your Round: How Much to Raise and at What Valuation
The wrong valuation kills more rounds than a weak deck ever will.
Jul 20
•
Martyn Eeles
6
Share this post
HealthVC
Pricing Your Round: How Much to Raise and at What Valuation
Copy link
Facebook
Email
Notes
More
From Pass to Close: The Founder’s Guide to Rejection Recovery
How to Turn a VC's 'No' Into Your Next Strategic Advantage
Jul 17
•
Martyn Eeles
1
Share this post
HealthVC
From Pass to Close: The Founder’s Guide to Rejection Recovery
Copy link
Facebook
Email
Notes
More
The Data Room Blueprint: What Investors Actually Want to See
How to Build a Data Room That Earns Investor Trust and Closes Capital Faster
Jul 13
•
Martyn Eeles
1
Share this post
HealthVC
The Data Room Blueprint: What Investors Actually Want to See
Copy link
Facebook
Email
Notes
More
4
How to Turn an LP’s “Maybe” into “Send the Docs
Why GPs stall out and how to restart the conversation with conviction
Jul 6
•
Martyn Eeles
1
Share this post
HealthVC
How to Turn an LP’s “Maybe” into “Send the Docs
Copy link
Facebook
Email
Notes
More
How Founders Are Manufacturing Momentum (Without Lying)
What top-performing founders know about timing, FOMO, and the psychology of a hot round
Jul 3
•
Martyn Eeles
2
Share this post
HealthVC
How Founders Are Manufacturing Momentum (Without Lying)
Copy link
Facebook
Email
Notes
More
June 2025
The Only 3 Slides That Actually Matter
A full teardown of how to structure your first 3 slides for maximum investor attention
Jun 29
•
Martyn Eeles
5
Share this post
HealthVC
The Only 3 Slides That Actually Matter
Copy link
Facebook
Email
Notes
More
Why Most Founders Fail to Raise in 2025 And How You Won’t
The new playbook for closing €500k–€5M rounds without wasting 90 days on hope and warm intros
Jun 22
•
Martyn Eeles
2
Share this post
HealthVC
Why Most Founders Fail to Raise in 2025 And How You Won’t
Copy link
Facebook
Email
Notes
More
2
What LPs Are Asking About Healthtech Funds in 2025
A Playbook for Founders and Emerging Managers Who Want to Raise Real Capital in a Tighter Market
Jun 19
•
Martyn Eeles
5
Share this post
HealthVC
What LPs Are Asking About Healthtech Funds in 2025
Copy link
Facebook
Email
Notes
More
Proprietary Deal Flow: The Quiet Engine of Top-Tier Venture Funds
In venture, the best deals don’t knock, they whisper. Here's how top funds source them before anyone else knows they exist.
Jun 15
•
Martyn Eeles
3
Share this post
HealthVC
Proprietary Deal Flow: The Quiet Engine of Top-Tier Venture Funds
Copy link
Facebook
Email
Notes
More
The Fine Print That Protects Millions: Why Covenants Matter in VC Deals
Unlock the key to safer investments and stronger founder relationships with this deep dive into venture covenants
Jun 8
•
Martyn Eeles
3
Share this post
HealthVC
The Fine Print That Protects Millions: Why Covenants Matter in VC Deals
Copy link
Facebook
Email
Notes
More
Blitzscaling: Speed, Uncertainty, and the High-Stakes Race for Market Dominance
What VCs in Life Sciences Can Learn from One of Tech’s Riskiest Growth Strategies
Jun 5
•
Martyn Eeles
5
Share this post
HealthVC
Blitzscaling: Speed, Uncertainty, and the High-Stakes Race for Market Dominance
Copy link
Facebook
Email
Notes
More
Hockey Stick Growth in Life Sciences: The Dream, the Data, and the Discipline
Why explosive growth in life sciences looks different — and how great investors recognize it before it happens.
Jun 1
•
Martyn Eeles
3
Share this post
HealthVC
Hockey Stick Growth in Life Sciences: The Dream, the Data, and the Discipline
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
